17-beta-hydroxysteroid dehydrogenase deficiency: Difference between revisions
Gerald Chi- (talk | contribs) mNo edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Infobox_Disease | | {{Infobox_Disease | | ||
Name = | Name = | ||
congenital adrenal hyperplasia due to CYP17A1 deficiencies | | |||
Image = | | Image = | | ||
Caption = | | Caption = | |
Revision as of 15:32, 18 July 2017
congenital adrenal hyperplasia due to CYP17A1 deficiencies | |
OMIM | 264300 |
---|---|
DiseasesDB | 32638 |
For patient information, click here
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
17-beta-hydroxysteroid dehydrogenase deficiency On the Web |
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency |
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Synonyms and keywords: HSD17B10 deficiency; HSD10 deficiency; 3-hydroxyacyl-CoA dehydrogenase II deficiency; 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency; MHBD deficiency
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Molecular Genetic Studies | Genotyping | Pelvic X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies